The Reditest Panel-Dip Substance Abuse Screening Device rapidly screens for a broad range of illicit and prescription drugs.
1. Drugs of abuse: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC150 or COC300), Marijuana (THC), Ecstasy (MDMA) Methadone (MTD), Methamphetamine (mAMP1000 or mAMP500), Opiates (OPI300 or OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), and Tricyclic Antidepressants (TCA).
For professional in-vitro diagnostic use only.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.
Gas chromatography-mass spectrometry (GC/MS) is the preferred confirmatory methods.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Based on your current location, the content on this page may not be relevant for your country.
